Health Fund Takes Seroquel Fraud Suit To 11th Circ.

Law360, New York (August 19, 2009, 2:04 PM EDT) -- A Pennsylvania health fund has decided to appeal the dismissal of its suit against AstraZeneca Pharmaceuticals LP alleging that the drugmaker's misleading marketing led to the fund improperly paying millions in reimbursements for prescriptions of the antipsychotic Seroquel.

In a notice filed with the U.S. District Court for the Middle District of Florida on Tuesday, the Pennsylvania Employees Benefit Trust Fund said it had appealed the court's final order of dismissal, entered July 20, to the U.S. Court of Appeals for the Eleventh Circuit.

Abigail Baron,...
To view the full article, register now.